# Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

> **NCT04728633** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Thomas Jefferson University** · enrollment: 28 (actual)

## Conditions studied

- Metastatic Malignant Neoplasm in the Liver
- Metastatic Uveal Melanoma
- Stage IV Choroidal and Ciliary Body Melanoma AJCC V8

## Interventions

- **DRUG:** Carmustine
- **DRUG:** Ethiodized Oil
- **PROCEDURE:** Transarterial Chemoembolization
- **OTHER:** Medical Device Usage and Evaluation

## Key facts

- **NCT ID:** NCT04728633
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-27
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04728633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04728633, "Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04728633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*